Midwest Sarcoma Trials Partnership

Midwest Sarcoma trials partnership

Clinical Trials

TRIAL 1

A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas (Closed).

Find it here.

TRIAL 3

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy(Closed. In Press)

Find it here.

TRIAL 5

Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration

Find it here.

Trial 2

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma (Closed).

Find it here.

Trial 4

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas. (Closed).

Find it here.